Gross Profit - Mabwell Shanghai Bioscience Co Ltd (SSE:688062) - Alpha Spread
M

Mabwell Shanghai Bioscience Co Ltd
SSE:688062

Watchlist Manager
Mabwell Shanghai Bioscience Co Ltd
SSE:688062
Watchlist
Price: 21.24 CNY -0.28% Market Closed
Market Cap: 8.5B CNY
Have any thoughts about
Mabwell Shanghai Bioscience Co Ltd?
Write Note

Mabwell Shanghai Bioscience Co Ltd
Gross Profit

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Mabwell Shanghai Bioscience Co Ltd
Gross Profit Peer Comparison

Comparables:
6160
1801
9926
603392
300122

Competitive Gross Profit Analysis
Latest Figures & CAGR of Competitors

Company Gross Profit CAGR 3Y CAGR 5Y CAGR 10Y
M
Mabwell Shanghai Bioscience Co Ltd
SSE:688062
Gross Profit
ÂĄ120.5m
CAGR 3-Years
N/A
CAGR 5-Years
62%
CAGR 10-Years
N/A
Beigene Ltd
HKEX:6160
Gross Profit
ÂĄ14.7B
CAGR 3-Years
108%
CAGR 5-Years
67%
CAGR 10-Years
N/A
Innovent Biologics Inc
HKEX:1801
Gross Profit
ÂĄ5.1B
CAGR 3-Years
14%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Akeso Inc
HKEX:9926
Gross Profit
ÂĄ4.4B
CAGR 3-Years
N/A
CAGR 5-Years
335%
CAGR 10-Years
N/A
Beijing Wantai Biological Pharmacy Enterprise Co Ltd
SSE:603392
Gross Profit
ÂĄ4.5B
CAGR 3-Years
34%
CAGR 5-Years
45%
CAGR 10-Years
N/A
Chongqing Zhifei Biological Products Co Ltd
SZSE:300122
Gross Profit
ÂĄ11.7B
CAGR 3-Years
3%
CAGR 5-Years
26%
CAGR 10-Years
38%

See Also

What is Mabwell Shanghai Bioscience Co Ltd's Gross Profit?
Gross Profit
120.5m CNY

Based on the financial report for Dec 31, 2023, Mabwell Shanghai Bioscience Co Ltd's Gross Profit amounts to 120.5m CNY.

What is Mabwell Shanghai Bioscience Co Ltd's Gross Profit growth rate?
Gross Profit CAGR 5Y
62%

Over the last year, the Gross Profit growth was 369%.

Back to Top